These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 893663)
1. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. Donaldson VH; Kleniewski J; Saito H; Sayed JK J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663 [TBL] [Abstract][Full Text] [Related]
2. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795 [TBL] [Abstract][Full Text] [Related]
3. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen. Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954 [No Abstract] [Full Text] [Related]
4. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. Scott CF; Colman RW J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688 [TBL] [Abstract][Full Text] [Related]
5. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. Revak SD; Cochrane CG; Griffin JH J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009 [TBL] [Abstract][Full Text] [Related]
6. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. Scicli AG; Mindroiu T; Scicli G; Carretero OA J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569 [TBL] [Abstract][Full Text] [Related]
7. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion. Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267 [TBL] [Abstract][Full Text] [Related]
8. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191 [No Abstract] [Full Text] [Related]
9. Flaujeac trait. Deficiency of human plasma kininogen. Wuepper KD; Miller DR; Lacombe MJ J Clin Invest; 1975 Dec; 56(6):1663-72. PubMed ID: 127805 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091 [TBL] [Abstract][Full Text] [Related]
11. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency]. Iijima K; Nakamura K Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236 [TBL] [Abstract][Full Text] [Related]
12. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. Meier HL; Pierce JV; Colman RW; Kaplan AP J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082 [TBL] [Abstract][Full Text] [Related]
13. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation. Saito H; Ratnoff OD Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254 [TBL] [Abstract][Full Text] [Related]
14. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
15. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Mandle RJ; Colman RW; Kaplan AP Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308 [TBL] [Abstract][Full Text] [Related]
16. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089 [TBL] [Abstract][Full Text] [Related]
17. Assay methods for prekallikrein and kininogens and their applications. Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307 [TBL] [Abstract][Full Text] [Related]
18. Purification of high molecular weight kininogen and the role of this agent in blood coagulation. Saito H J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664 [TBL] [Abstract][Full Text] [Related]
19. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. Saito H; Goldsmith GH Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316 [TBL] [Abstract][Full Text] [Related]
20. Association of factor XI and high molecular weight kininogen in human plasma. Thompson RE; Mandle R; Kaplan AP J Clin Invest; 1977 Dec; 60(6):1376-80. PubMed ID: 915004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]